Logo image of VEE.DE

VEEVA SYSTEMS INC-CLASS A (VEE.DE) Stock Fundamental Analysis

FRA:VEE - Deutsche Boerse Ag - US9224751084 - Common Stock - Currency: EUR

221.1  +20.8 (+10.38%)

Fundamental Rating

6

Taking everything into account, VEE scores 6 out of 10 in our fundamental rating. VEE was compared to 12 industry peers in the Health Care Technology industry. VEE gets an excellent profitability rating and is at the same time showing great financial health properties. VEE shows excellent growth, but is valued quite expensive already. This makes VEE very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

VEE had positive earnings in the past year.
In the past year VEE had a positive cash flow from operations.
In the past 5 years VEE has always been profitable.
Each year in the past 5 years VEE had a positive operating cash flow.
VEE.DE Yearly Net Income VS EBIT VS OCF VS FCFVEE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of VEE (9.73%) is better than 83.33% of its industry peers.
The Return On Equity of VEE (12.24%) is better than 75.00% of its industry peers.
VEE has a better Return On Invested Capital (9.79%) than 83.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VEE is in line with the industry average of 7.83%.
The last Return On Invested Capital (9.79%) for VEE is above the 3 year average (9.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.73%
ROE 12.24%
ROIC 9.79%
ROA(3y)9.59%
ROA(5y)10.49%
ROE(3y)12.23%
ROE(5y)13.63%
ROIC(3y)9.16%
ROIC(5y)11.04%
VEE.DE Yearly ROA, ROE, ROICVEE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 26.00%, VEE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of VEE has remained more or less at the same level.
The Operating Margin of VEE (25.36%) is better than 100.00% of its industry peers.
VEE's Operating Margin has been stable in the last couple of years.
VEE's Gross Margin of 74.53% is in line compared to the rest of the industry. VEE outperforms 58.33% of its industry peers.
VEE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.36%
PM (TTM) 26%
GM 74.53%
OM growth 3Y-2.45%
OM growth 5Y-0.44%
PM growth 3Y4.03%
PM growth 5Y-0.95%
GM growth 3Y0.79%
GM growth 5Y0.55%
VEE.DE Yearly Profit, Operating, Gross MarginsVEE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VEE is destroying value.
The number of shares outstanding for VEE has been increased compared to 1 year ago.
VEE has more shares outstanding than it did 5 years ago.
VEE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VEE.DE Yearly Shares OutstandingVEE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
VEE.DE Yearly Total Debt VS Total AssetsVEE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

VEE has an Altman-Z score of 17.66. This indicates that VEE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 17.66, VEE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VEE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.66
ROIC/WACC0.92
WACC10.67%
VEE.DE Yearly LT Debt VS Equity VS FCFVEE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

VEE has a Current Ratio of 4.51. This indicates that VEE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of VEE (4.51) is better than 91.67% of its industry peers.
A Quick Ratio of 4.51 indicates that VEE has no problem at all paying its short term obligations.
The Quick ratio of VEE (4.51) is better than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 4.51
Quick Ratio 4.51
VEE.DE Yearly Current Assets VS Current LiabilitesVEE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

7

3. Growth

3.1 Past

VEE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.57%, which is quite impressive.
VEE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.72% yearly.
Looking at the last year, VEE shows a quite strong growth in Revenue. The Revenue has grown by 16.20% in the last year.
Measured over the past years, VEE shows a quite strong growth in Revenue. The Revenue has been growing by 19.99% on average per year.
EPS 1Y (TTM)36.57%
EPS 3Y21.12%
EPS 5Y24.72%
EPS Q2Q%26.09%
Revenue 1Y (TTM)16.2%
Revenue growth 3Y14.06%
Revenue growth 5Y19.99%
Sales Q2Q%14.31%

3.2 Future

Based on estimates for the next years, VEE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.71% on average per year.
VEE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.07% yearly.
EPS Next Y6.62%
EPS Next 2Y8.95%
EPS Next 3Y10.9%
EPS Next 5Y10.71%
Revenue Next Year12.16%
Revenue Next 2Y12.39%
Revenue Next 3Y12.65%
Revenue Next 5Y13.07%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VEE.DE Yearly Revenue VS EstimatesVEE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
VEE.DE Yearly EPS VS EstimatesVEE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.31, VEE can be considered very expensive at the moment.
Based on the Price/Earnings ratio, VEE is valued a bit cheaper than 66.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. VEE is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 34.06 indicates a quite expensive valuation of VEE.
VEE's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, VEE is valued quite expensively.
Industry RankSector Rank
PE 36.31
Fwd PE 34.06
VEE.DE Price Earnings VS Forward Price EarningsVEE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

VEE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. VEE is more expensive than 66.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VEE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 36.44
EV/EBITDA 40.49
VEE.DE Per share dataVEE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VEE does not grow enough to justify the current Price/Earnings ratio.
VEE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.48
PEG (5Y)1.47
EPS Next 2Y8.95%
EPS Next 3Y10.9%

0

5. Dividend

5.1 Amount

VEE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VEEVA SYSTEMS INC-CLASS A

FRA:VEE (3/6/2025, 7:00:00 PM)

221.1

+20.8 (+10.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-28 2025-05-28/amc
Inst Owners84.77%
Inst Owner ChangeN/A
Ins Owners8.83%
Ins Owner ChangeN/A
Market Cap35.90B
Analysts77.37
Price Target257.16 (16.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.29%
Min EPS beat(2)7.97%
Max EPS beat(2)8.61%
EPS beat(4)4
Avg EPS beat(4)5.82%
Min EPS beat(4)3.17%
Max EPS beat(4)8.61%
EPS beat(8)8
Avg EPS beat(8)5.77%
EPS beat(12)11
Avg EPS beat(12)5.29%
EPS beat(16)15
Avg EPS beat(16)5.79%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)0.59%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-0.82%
Max Revenue beat(4)0.59%
Revenue beat(8)2
Avg Revenue beat(8)-0.63%
Revenue beat(12)2
Avg Revenue beat(12)-0.62%
Revenue beat(16)4
Avg Revenue beat(16)-0.3%
PT rev (1m)-0.02%
PT rev (3m)6.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.49%
EPS NY rev (1m)0%
EPS NY rev (3m)2.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE 36.31
Fwd PE 34.06
P/S 14.19
P/FCF 36.44
P/OCF 35.75
P/B 6.68
P/tB 7.29
EV/EBITDA 40.49
EPS(TTM)6.09
EY2.75%
EPS(NY)6.49
Fwd EY2.94%
FCF(TTM)6.07
FCFY2.74%
OCF(TTM)6.18
OCFY2.8%
SpS15.58
BVpS33.09
TBVpS30.34
PEG (NY)5.48
PEG (5Y)1.47
Profitability
Industry RankSector Rank
ROA 9.73%
ROE 12.24%
ROCE 11.72%
ROIC 9.79%
ROICexc 73.54%
ROICexgc 189.64%
OM 25.36%
PM (TTM) 26%
GM 74.53%
FCFM 38.94%
ROA(3y)9.59%
ROA(5y)10.49%
ROE(3y)12.23%
ROE(5y)13.63%
ROIC(3y)9.16%
ROIC(5y)11.04%
ROICexc(3y)59.89%
ROICexc(5y)59.49%
ROICexgc(3y)196.73%
ROICexgc(5y)318.62%
ROCE(3y)10.96%
ROCE(5y)13.22%
ROICexcg growth 3Y-36.21%
ROICexcg growth 5Y-13.57%
ROICexc growth 3Y1.45%
ROICexc growth 5Y14.29%
OM growth 3Y-2.45%
OM growth 5Y-0.44%
PM growth 3Y4.03%
PM growth 5Y-0.95%
GM growth 3Y0.79%
GM growth 5Y0.55%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 52.1%
Cap/Sales 0.75%
Interest Coverage 250
Cash Conversion 148.14%
Profit Quality 149.76%
Current Ratio 4.51
Quick Ratio 4.51
Altman-Z 17.66
F-Score7
WACC10.67%
ROIC/WACC0.92
Cap/Depr(3y)59.59%
Cap/Depr(5y)52.02%
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.77%
Profit Quality(3y)158.47%
Profit Quality(5y)158.74%
High Growth Momentum
Growth
EPS 1Y (TTM)36.57%
EPS 3Y21.12%
EPS 5Y24.72%
EPS Q2Q%26.09%
EPS Next Y6.62%
EPS Next 2Y8.95%
EPS Next 3Y10.9%
EPS Next 5Y10.71%
Revenue 1Y (TTM)16.2%
Revenue growth 3Y14.06%
Revenue growth 5Y19.99%
Sales Q2Q%14.31%
Revenue Next Year12.16%
Revenue Next 2Y12.39%
Revenue Next 3Y12.65%
Revenue Next 5Y13.07%
EBIT growth 1Y62.24%
EBIT growth 3Y11.27%
EBIT growth 5Y19.47%
EBIT Next Year11.99%
EBIT Next 3Y15.57%
EBIT Next 5Y14.78%
FCF growth 1Y20.83%
FCF growth 3Y12.54%
FCF growth 5Y19.82%
OCF growth 1Y19.61%
OCF growth 3Y12.55%
OCF growth 5Y20.04%